{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:04:04Z","timestamp":1770455044453,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,14]]},"DOI":"10.7759\/cureus.90070","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T12:01:15Z","timestamp":1755172875000},"source":"Crossref","is-referenced-by-count":1,"title":["Disseminated Kaposi Sarcoma With Ocular Involvement: An Unusual Multisystem Case Presentation"],"prefix":"10.7759","author":[{"given":"Ana de Lourdes","family":"Torralbas Fitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idania Maria","family":"Cruzata Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio Jose","family":"Torralbas Fitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliany","family":"Leon Figueredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Blanco Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Global patterns and trends in Kaposi sarcoma incidence: a population-based study","volume":"11","author":"Fu L","year":"2023","unstructured":"Fu L, Tian T, Wang B, et al.. Global patterns and trends in Kaposi sarcoma incidence: a population-based study. Lancet Glob Health. 2023, 11:e1566-75.","journal-title":"Lancet Glob Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0275","article-title":"Kaposi sarcoma herpesvirus pathogenesis","volume":"372","author":"Mariggi\u00f2 G","year":"2017","unstructured":"Mariggi\u00f2 G, Koch S, Schulz TF. Kaposi sarcoma herpesvirus pathogenesis. Philos Trans R Soc Lond B Biol Sci. 2017, 372:0. 10.1098\/rstb.2016.0275","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee","volume":"7","author":"Krown SE","year":"1989","unstructured":"Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1989, 7:1201-7. 10.1200\/JCO.1989.7.9.1201","journal-title":"J Clin Oncol"},{"key":"ref4","article-title":"Kaposi sarcoma","author":"Bishop BN","year":"2025","unstructured":"Bishop BN, Lynch DT. Kaposi sarcoma. StatPearls. StatPearls Publishing, Treasure Island, FL; 2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.77213","article-title":"A retrospective study on the incidence of Kaposi sarcoma in the United States from 1999 to 2020 using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (CDC Wonder) Database","volume":"17","author":"Balasubramanian D","year":"2025","unstructured":"Balasubramanian D, Srinivasan S, Paul PM, Ko N, Garlapati S. A retrospective study on the incidence of Kaposi sarcoma in the United States from 1999 to 2020 using the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiological Research (CDC Wonder) Database. Cureus. 2025, 17:e77213. 10.7759\/cureus.77213","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33951","article-title":"Burden of Kaposi sarcoma according to HIV status: a systematic review and global analysis","volume":"150","author":"Ibrahim Khalil A","year":"2022","unstructured":"Ibrahim Khalil A, Franceschi S, de Martel C, Bray F, Clifford GM. Burden of Kaposi sarcoma according to HIV status: a systematic review and global analysis. Int J Cancer. 2022, 150:1948-57. 10.1002\/ijc.33951","journal-title":"Int J Cancer"},{"key":"ref7","article-title":"Kaposi Sarcoma Treatment (PDQ\u00ae). Health Professional Version","author":"PDQ Adult Treatment Editorial Board","year":"2002","unstructured":"PDQ Adult Treatment Editorial Board. Kaposi Sarcoma Treatment (PDQ\u00ae). Health Professional Version. National Cancer Institute, Bethesda, MD; 2002."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/17469899.2021.1962294","article-title":"Spotlight on ocular Kaposi's sarcoma: an update on the presentation, diagnosis, and management options","volume":"16","author":"Venkateswaran N","year":"2021","unstructured":"Venkateswaran N, Ramos JC, Cohen AK, Alvarez OP, Cohen NK, Galor A, Karp CL. Spotlight on ocular Kaposi's sarcoma: an update on the presentation, diagnosis, and management options. Expert Rev Ophthalmol. 2021, 16:477-89. 10.1080\/17469899.2021.1962294","journal-title":"Expert Rev Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13225692","article-title":"Epidemiology of Kaposi's sarcoma","volume":"13","author":"Grabar S","year":"2021","unstructured":"Grabar S, Costagliola D. Epidemiology of Kaposi's sarcoma. Cancers (Basel). 2021, 13:5692. 10.3390\/cancers13225692","journal-title":"Cancers (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002553","article-title":"Atypical presentation of Kaposi sarcoma in an HIV-negative patient: a case report and comprehensive literature review","volume":"86","author":"Jebrini NE","year":"2024","unstructured":"Jebrini NE, Natsheh MA, Jaber M, Muhtaseb R, Qunaibi Y, Hidri H, Sarahneh HA. Atypical presentation of Kaposi sarcoma in an HIV-negative patient: a case report and comprehensive literature review. Ann Med Surg (Lond). 2024, 86:7325-9. 10.1097\/MS9.0000000000002553","journal-title":"Ann Med Surg (Lond)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70036-0","article-title":"Management of AIDS-related Kaposi's sarcoma","volume":"8","author":"Di Lorenzo G","year":"2007","unstructured":"Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, Di Trolio R, De Placido S, Dezube BJ. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol. 2007, 8:167-76. 10.1016\/S1470-2045(07)70036-0","journal-title":"Lancet Oncol"},{"key":"ref12","unstructured":"Kaposi sarcoma pathology. (2010). Accessed. August 12, 2025: https:\/\/dermnetnz.org\/topics\/kaposi-sarcoma-pathology."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S468787","article-title":"Management and future therapeutic perspectives of classic Kaposi's sarcoma: an evidence-based review","volume":"17","author":"Denaro N","year":"2024","unstructured":"Denaro N, Indini A, Brambilla L, Marzano AV, Garrone O, Tourlaki A. Management and future therapeutic perspectives of classic Kaposi's sarcoma: an evidence-based review. Onco Targets Ther. 2024, 17:961-76. 10.2147\/OTT.S468787","journal-title":"Onco Targets Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.9.3085","article-title":"AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee","volume":"15","author":"Krown SE","year":"1997","unstructured":"Krown SE, Testa MA, Huang J. AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1997, 15:3085-92. 10.1200\/JCO.1997.15.9.3085","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.24-0584","article-title":"Regression of clinically diagnosed ocular Kaposi sarcoma post-initiation of highly active antiretroviral therapy","volume":"112","author":"Francis C","year":"2025","unstructured":"Francis C, Da Silva K, Grosvenor D. Regression of clinically diagnosed ocular Kaposi sarcoma post-initiation of highly active antiretroviral therapy. Am J Trop Med Hyg. 2025, 112:682-4. 10.4269\/ajtmh.24-0584","journal-title":"Am J Trop Med Hyg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/08820538.2025.2458658","article-title":"Immune checkpoint inhibitors in the treatment of ocular surface cancers: a review","volume":"40","author":"Li WJ","year":"2025","unstructured":"Li WJ, Najdawi W, Badla O, Galor A, Karp CL. Immune checkpoint inhibitors in the treatment of ocular surface cancers: a review. Semin Ophthalmol. 2025, 40:485-95. 10.1080\/08820538.2025.2458658","journal-title":"Semin Ophthalmol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397817-disseminated-kaposi-sarcoma-with-ocular-involvement-an-unusual-multisystem-case-presentation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T12:01:16Z","timestamp":1755172876000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397817-disseminated-kaposi-sarcoma-with-ocular-involvement-an-unusual-multisystem-case-presentation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,14]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.90070","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,14]]}}}